GSK : HIV expert feedback - The cabotegravir franchise is well positioned
>Validation of GSK’s long-acting strategy - It was our pleasure to welcome on Wednesday Professor Christine Katlama, doctor specialising in infectious and tropical diseases, as part of our Expert Access event on HIV. Professor Katlama’s presentation confirmed our positive view of the HIV market (treatment and PrEP) and GSK’s position and strategy in this area, with the launch of its long-acting products. As such, we model 2021-26e CAGR of 8.2% for the HIV division (21...
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.